VAERS reports by lot

Merck HPV lot N000326: VAERS reports

47 VAERS reports list lot N000326 as a Merck HPV vaccine, received between 2017-04-21 and 2018-08-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
47
Reports
4%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1428%
General / Systemic (non-local)918%
Allergic / Anaphylactic510%
Dermatological (non-injection-site)510%
Injection-site / Local reaction48%
Cardiac / Cardiovascular36%
Musculoskeletal36%
Autoimmune / Immune-mediated24%
Respiratory24%
Thrombotic / Hematological12%
Gastrointestinal12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey10
Pennsylvania9
California6
New York4
Minnesota2
Washington2
Michigan2
Tennessee1
Kentucky1
Connecticut1
Illinois1
North Dakota1

Reports by month received

2017-041
2017-051
2017-062
2017-073
2017-0811
2017-097
2017-103
2017-1110
2017-121
2018-056
2018-061
2018-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.